Nephrology And Urology Devices Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Ureteral Catheters, PCN Catheters, Urinary Stents, Urology Guidewires, Stone Basket), By Application (Urolithiasis), By End Use, By Region, And Segment Forecasts

Nephrology & Urology Devices Market Summary

The global nephrology and urology devices market size was estimated at USD 6.73 billion in 2025 and is projected to reach USD 11.73 billion by 2033, growing at a CAGR of 7.26% from 2026 to 2033. This growth is driven by the rising prevalence of chronic kidney disease, urolithiasis, and urinary system cancers, along with the increasing burden of diabetes and hypertension that contribute to long-term renal complications.

The growing adoption of minimally invasive and endourological procedures, including advanced catheterization, stenting, and stone management techniques, is further accelerating demand for specialized devices. In addition, expanding healthcare infrastructure, improved access to diagnostic and interventional urology services, and continuous innovation in biomaterials and device design are supporting procedural efficiency and patient outcomes. The shift toward outpatient and ambulatory surgical care, combined with increasing awareness of early diagnosis and treatment, is also contributing to sustained market expansion.

The rising prevalence of urological and renal disorders is a primary driver of growth in the nephrology and urology devices market. Conditions such as chronic kidney disease, kidney stones, and benign prostatic hyperplasia are increasing due to aging populations, sedentary lifestyles, diabetes, and hypertension. As these diseases progress, they require continuous clinical management, thereby increasing demand for a wide range of medical devices. For instance, CKD patients progress to end-stage renal disease, necessitating long-term dialysis supported by machines, dialyzers, and vascular access devices.

The growing incidence of kidney stones has led to a greater number of endourological procedures, such as ureteroscopy, which rely heavily on devices such as ureteral catheters, guidewires, and stone retrieval systems. In the case of BPH and other lower urinary tract disorders, increased patient volumes are driving the use of catheters, stents, and minimally invasive treatment devices. In addition, many of these conditions are chronic and recurrent, leading to repeated procedures and long-term device use, which significantly increases overall market demand. This sustained and expanding patient pool translates into higher procedural volumes and continuous consumption of disposable devices, making disease prevalence a key growth engine for the market.

Chronic Kidney Disease (CKD) - U.S. Key Statistics (2026)

Source: CDC, 2026

Diabetes is a major growth driver for the nephrology & urology devices market because it is one of the leading causes of chronic kidney disease and diabetic nephropathy, which progressively damage kidney function and increase the need for long-term renal care. Persistently high blood glucose levels in diabetic patients accelerate kidney filtration damage, leading to higher rates of end-stage renal disease that require dialysis access devices, catheters, and urinary management systems. In addition, diabetic patients are more prone to urinary tract infections, bladder dysfunction, and post-surgical complications, which increases the use of intermittent catheters, Foley catheters, and urological drainage devices. The rising global prevalence of type 2 diabetes, driven by aging populations, sedentary lifestyles, and obesity, further expands the patient pool requiring nephrology and urology interventions. As a result, healthcare systems are witnessing growing demand for both acute and chronic management solutions, strengthening the adoption of advanced minimally invasive devices and long-term renal care technologies.

Diabetes estimates (20-79 y) (People with diabetes, in 1,000s)

Source: International Diabetes Federation

The growing incidence of urinary system cancers, particularly bladder cancer and kidney and renal pelvis cancer, is a key driver of the nephrology & urology devices market, as these conditions require both surgical and long-term interventional management. Treatment pathways for urinary cancers frequently involve procedures such as tumor resection, urinary diversion, stent placement, and catheterization to restore or maintain urine flow, which directly increases demand for urology devices. In addition, post-surgical complications and disease recurrence further sustain the need for urinary drainage systems, guidewires, and minimally invasive endourology instruments. The increasing adoption of advanced diagnostic and minimally invasive techniques is also expanding procedural volumes in urology departments, thereby supporting greater utilization of specialized devices. The rising burden of urinary system cancers is creating sustained demand across both hospital-based interventions and outpatient urological care, strengthening long-term growth of the nephrology & urology devices market.

Estimated New Cancer Cases and Deaths - Urinary System (U.S., 2026)

Source: American Cancer Society

Market Concentration & Characteristics

The nephrology & urology devices industry is in a strong growth stage, with an accelerating expansion trajectory. Market growth is primarily driven by the rising burden of chronic kidney disease, urolithiasis, and other urological disorders, along with increasing adoption of minimally invasive and catheter-based procedures. Expanding use of advanced urinary drainage systems, stents, guidewires, and dialysis-related devices, supported by improved clinical awareness and growing healthcare infrastructure, is further strengthening demand across both hospital and outpatient settings.

The degree of innovation in the industry is high and rapidly accelerating, driven by continuous advancements in device materials, design engineering, and integration of digital health technologies. Manufacturers are increasingly focusing on developing next-generation solutions such as antimicrobial and anti-encrustation coated catheters, drug-eluting and bioresorbable ureteral stents, and hydrophilic guidewires to reduce complications like infection, blockage, and tissue irritation. In addition, innovations in minimally invasive surgical systems, laser lithotripsy, and robotic-assisted urological procedures are improving procedural precision and patient outcomes while reducing recovery time.

The level of M&A activity in the industry is moderate to high, with a clear upward trend driven by portfolio consolidation and strategic expansion by major medtech players. Companies are actively acquiring niche urology and renal device manufacturers to strengthen their presence in high-growth segments such as minimally invasive endourology, urinary drainage systems, and dialysis-related consumables.

In January 2026, Boston Scientific announced an agreement to acquire Valencia Technologies Corporation to expand its urology portfolio. The Boston Scientific acquisition of Valencia Technologies reflects the broader expansion of minimally invasive urology treatments, which, in turn, supports the market. 

The industry is witnessing regional expansion driven by increasing investments in healthcare infrastructure, rising burden of renal and urological diseases, and improved access to specialized care services across both developed and emerging economies. In September 2025, B. Braun expanded and modernized its U.S. manufacturing facility in Hanover Township, Pennsylvania, investing in production capacity

Product Insights

The others segment held a major share of the market in 2025, primarily due to the wide usage of supportive and adjunctive products that are essential across multiple renal and urological procedures. This segment includes a broad range of consumables and devices used in routine clinical practice, such as drainage systems, accessories, and miscellaneous urology tools that are frequently required in hospitals and surgical settings. The high procedural volume for conditions like urinary tract disorders, kidney diseases, and post-operative care has significantly contributed to the dominance of this segment. In addition, the recurring demand for single-use products, driven by infection control protocols and the shift toward minimally invasive procedures, has further strengthened its market position.

The PCN (percutaneous nephrostomy) catheters segment is expected to expand at the fastest CAGR due to the rising incidence of kidney obstruction cases, including urolithiasis, tumors, and post-surgical complications that require urgent urinary drainage. Increasing adoption of minimally invasive procedures in hospital and emergency care settings is further supporting the demand for PCN catheters, as they provide an effective and less invasive solution for restoring urinary flow and managing acute renal conditions. In addition, improvements in catheter design, imaging-guided placement techniques, and the growing availability of interventional radiology services are enhancing procedural success rates and driving wider clinical acceptance. Rising awareness among clinicians regarding early decompression of obstructed kidneys is also contributing to faster adoption of PCN catheterization across healthcare facilities.

Application Insights

Urolithiasis dominated the market in 2025, primarily due to the high global prevalence of kidney stone disease and the increasing adoption of minimally invasive stone management procedures. The condition requires frequent use of urological devices such as catheters, guidewires, stents, stone baskets, and dilators during interventions like ureteroscopy and laser lithotripsy, which significantly drives procedural volumes. In addition, the recurrent nature of kidney stones leads to repeat treatments, further strengthening demand. Growing preference for endourological techniques over open surgery, along with improved diagnostic capabilities and faster treatment access, has further strengthened the dominance of this segment.

The kidney diseases segment is expected to grow at the fastest CAGR, primarily driven by the rising global burden of chronic kidney disease (CKD), increasing prevalence of diabetes and hypertension, and a growing aging population. The segment is witnessing strong demand for long-term renal care solutions such as dialysis support devices, catheters, drainage systems, and other urological accessories due to the progressive and irreversible nature of kidney dysfunction. In addition, improved awareness, expanding screening programs, and better access to healthcare services are leading to earlier diagnosis and longer treatment pathways, further increasing device utilization. The continuous need for disease management and repeated clinical interventions makes this segment the most dynamic and fastest-growing within the market.

End Use Insights

Hospitals dominated the nephrology & urology devices market in 2025, primarily due to their ability to manage high patient volumes and provide comprehensive care for complex renal and urological conditions. They serve as the primary setting for advanced diagnostic procedures, surgical interventions, dialysis treatments, and emergency care related to kidney obstruction, stone disease, and chronic kidney disorders. The availability of specialized urology departments, skilled healthcare professionals, and advanced medical technologies such as endoscopic systems, catheters, stents, and lithotripsy devices further strengthens their leading position. Hospitals benefit from strong patient inflow and reimbursement support, making them the central hub for acute and chronic nephrology and urology treatments.

Ambulatory Surgical Centers (ASCs) are expected to register the fastest CAGR during the forecast period, driven by the growing shift toward outpatient and minimally invasive procedures in nephrology and urology care. These facilities offer cost-effective treatment options with shorter hospital stays, faster patient recovery, and improved operational efficiency compared to traditional hospital settings. Increasing adoption of procedures such as stone removal, catheter-based interventions, and minor urological surgeries in ASCs is further accelerating demand for advanced disposable devices, including catheters, guidewires, and stone management tools. In addition, rising healthcare cost pressures and advancements in minimally invasive technologies are encouraging both patients and providers to prefer ASCs, supporting their rapid growth.

Regional Insights

The nephrology & urology devices market in North America is driven by a high prevalence of chronic kidney disease and other underlying risk factors such as diabetes, hypertension, and obesity, which continue to increase the demand for long-term renal care and urological interventions. A well-developed healthcare infrastructure, along with strong access to specialized hospitals, dialysis centers, and urology clinics, further supports consistent procedural volumes across the region.

In addition, favorable reimbursement systems and insurance coverage enable wider patient access to advanced treatments and devices, encouraging early diagnosis and treatment adoption. The region also sees strong growth of minimally invasive procedures, including endourology and stone management techniques, which increases the use of catheters, stents, guidewires, and other disposables. Furthermore, continuous technological innovation and rapid adoption of advanced medical technologies by leading healthcare providers and device manufacturers are key factors supporting sustained market growth.

U.S. Nephrology & Urology Devices Market Trends

The nephrology & urology devices market in the U.S. is driven by a high and increasing burden of chronic kidney disease, diabetes, and hypertension, which are leading causes of renal failure and urological complications. The country has one of the largest dialysis populations globally, supported by a well-established renal care infrastructure and extensive availability of outpatient dialysis centers. The rising incidence of urolithiasis, benign prostatic hyperplasia, urinary incontinence, and urological cancers is further increasing demand for catheters, stents, guidewires, and stone management devices.

• According to CDC 2026, in the U.S., chronic kidney disease (CKD) represents a major public health burden, with recent estimates indicating that more than 1 in 10 adults (around 14% or approximately 37 million people) are affected.

In addition, strong adoption of minimally invasive procedures such as ureteroscopy, laser lithotripsy, and endourology techniques is accelerating the use of advanced disposable and single-use devices. The presence of favorable reimbursement policies through Medicare and private insurers also ensures high procedural access and affordability, supporting sustained demand. Moreover, continuous technological innovation by leading medical device companies, along with early adoption of advanced products such as antimicrobial catheters and next-generation stents, is further strengthening market growth.

Europe Nephrology & Urology Devices Market Trends

The nephrology and urology devices market in Europe held a substantial revenue share in 2025, driven by the high burden of chronic kidney disease, urolithiasis, and age-related urological disorders across the region’s aging population. Strong healthcare infrastructure, widespread access to advanced diagnostic and interventional urology procedures, and well-established reimbursement systems are further supporting market adoption. The increasing prevalence of diabetes and hypertension is also contributing to higher rates of renal complications, boosting demand for dialysis-related devices, catheters, stents, and urinary drainage systems. In addition, the region’s strong focus on minimally invasive surgical techniques and early disease management is accelerating the uptake of advanced endourology and catheter-based technologies across hospitals and specialty clinics.

As per data published by the University of Glasgow in November 2025, in the UK, around 11.9% of adults, or 6.3 million, are estimated to have CKD. In Western Europe, 12.4% adults are estimated to have CKD.

Germany nephrology & urology devices market is driven by the ongoing expansion of renal care services and by increasing investment in healthcare infrastructure to address the rising burden of chronic kidney disease and other urological disorders. Growing demand for dialysis, improved access to specialized care, and strengthening of hospital and clinic networks are increasing procedure volumes across the country. In addition, higher adoption of minimally invasive urology procedures and advanced treatment technologies is further supporting device utilization. Together, these factors are contributing to market growth by expanding patient access to diagnosis, treatment, and long-term renal care services.

In March 2025, Diaverum expanded its network to 18 clinics, serving over 1,470 patients with more than 455 staff, including facilities with up to 50 dialysis stations, capable of treating around 150 patients. Such expansions reflect the increasing demand for dialysis services and improved access to care.

The nephrology & urology devices market in the UK is witnessing growth, driven by the rising prevalence of chronic kidney disease, urolithiasis, and urological conditions such as benign prostatic hyperplasia and urinary incontinence. An aging population is a key contributor, as older individuals are more susceptible to kidney dysfunction and urological disorders, thereby increasing the demand for diagnostic and therapeutic interventions. In addition, the high burden of lifestyle-related diseases such as diabetes and hypertension continues to drive the incidence of renal complications, further supporting market expansion. The presence of a well-established healthcare system, particularly the National Health Service, ensures broad access to treatment, including dialysis, catheterization, and minimally invasive urological procedures.

According to the data published by the NIH, in the UK, the burden of benign prostatic hyperplasia is expected to increase significantly by 2025, driven primarily by the aging male population. Approximately 25% of men aged 40-79 years are affected by symptomatic BPH, and the total patient population is projected to rise from around 2.5 million to nearly 3.7-3.8 million.

Asia Pacific Nephrology & Urology Devices Market Trends

The nephrology & urology devices market in Asia Pacific is experiencing growth, driven by a combination of demographic, epidemiological, and healthcare system factors across countries such as China, India, Japan, South Korea, and Australia. A key growth driver is the rapidly increasing prevalence of chronic diseases, particularly diabetes and hypertension, which are major causes of chronic kidney disease and end-stage renal disease. The region also has a high and rising burden of urolithiasis and urological conditions, driven by changing dietary patterns, dehydration, and lifestyle factors.

Chronic Kidney Disease (CKD) - Key Statistics, Australia

Source: AIHW 2025

The India nephrology & urology devices market is growing, driven by the rising prevalence of chronic diseases such as hypertension and diabetes, which are key contributors to kidney disorders and renal failure. The increasing incidence of urolithiasis, benign prostatic hyperplasia, and urological cancers is further boosting the demand for advanced diagnostic and treatment solutions. In addition, expanding healthcare infrastructure, a growing number of dialysis centers, and improving access to minimally invasive urological procedures are supporting market growth. Government initiatives to enhance healthcare access, along with increasing awareness and early diagnosis, are also contributing to the rising adoption of nephrology and urology devices across India. According to the data published by AHA in December 2025, over 315 million adults live with hypertension in India, of whom only 37% are diagnosed.

The nephrology & urology devices market in China is experiencing growth, driven by the country’s expanding healthcare infrastructure, rising incidence of kidney and urological disorders, and increasing adoption of minimally invasive urological procedures. Government initiatives such as Healthy China 2030 are accelerating investments in advanced medical technologies and hospital capabilities, particularly in tier-1 and tier-2 cities.

Growing awareness among clinicians and patients, improving insurance coverage, and the expansion of urology and dialysis services are boosting demand for nephrology and urology devices. Domestic manufacturers are strengthening their market presence through product innovation, strategic partnerships, and regulatory approvals, while multinational medical device companies continue to expand distribution networks and clinical training programs.

Middle East & Africa Nephrology & Urology Devices Market Trends

The nephrology & urology devices market in the Middle East & Africa is witnessing steady growth, driven by rising healthcare investments, increasing prevalence of kidney and urological disorders, and expanding access to minimally invasive urological procedures. Governments across the region are strengthening healthcare infrastructure through long-term national transformation programs such as UAE Vision 2031, Saudi Vision 2030, and Qatar National Vision 2030, which emphasize the adoption of advanced medical technologies and specialized care services.

These initiatives are accelerating investments in hospitals, dialysis centers, and urology departments, thereby supporting the adoption of nephrology and urology devices, including catheters, stents, dialysis equipment, and stone management devices for the treatment of kidney diseases, urolithiasis, and other urological conditions.

Key Nephrology And Urology Devices Company Insights

The nephrology & urology devices market is characterized by intense competition among established global medical device companies and specialized urology-focused players. Leading companies are focused on expanding their urology and renal care portfolios through continuous product innovation, regulatory approvals, and strategic collaborations. Market participants are investing in advanced technologies such as antimicrobial-coated catheters, next-generation ureteral stents, and minimally invasive stone management devices to improve patient outcomes, reduce infection risks, and enhance procedural efficiency.

Recent Developments

• In January 2026, Medline Industries, LP. announced the opening of a new office in Riyadh, Saudi Arabia, as part of its strategy to expand its presence in the Middle East. This new facility strengthens Medline’s regional footprint and enhances service capabilities, enabling faster response times and improved customer engagement.

• In December 2025, ProVerum Limited announced that the U.S. FDA had approved its ProVee System, a next-generation prostatic urethral stent designed to treat benign prostatic hyperplasia. The ProVee System is a minimally invasive solution that relieves urinary obstruction by gently opening the prostate without cutting, burning, or damaging tissue. This approach is expected to offer improved safety outcomes and faster recovery compared to traditional surgical interventions.

• In March 2025, Fresenius Medical Care announced the expansion of its bibag production at its manufacturing plant in Jaguariúna, São Paulo, Brazil. The expansion began in March 2025 with a highly automated production line designed to serve both the Brazilian market and export demand across Latin America.

Nephrology And Urology Devices Market Report Scope

Global Nephrology And Urology Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global nephrology And urology devices market report based on product, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Ureteral Catheters

    • Intermittent Catheters

    • Foley / Indwelling Catheters

    • External Catheters

  • PCN Catheters

  • Urinary Stents

    • Metallic Ureteral Stents

    • Polymer Ureteral Stents

      • Silicone Stents

      • Polyurethane Stents

      • Hybrid Stents

  • Stone Basket

    • Disposable

    • Reusable

  • Urology Guidewires

    • Nitinol Guidewires

    • Stainless Steel Guidewires

    • PTFE Guidewires

    • Others

  • Renal Dilators

    • Disposable

    • Reusable

  • Other

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Urolithiasis

  • Urological Cancer & BPH

  • Bladder Disorders

  • Kidney Diseases

  • Others

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals

  • Clinics

  • Ambulatory Surgical Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait